vs

Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and TEAM INC (TISI). Click either name above to swap in a different company.

TEAM INC is the larger business by last-quarter revenue ($224.8M vs $123.8M, roughly 1.8× NATURES SUNSHINE PRODUCTS INC). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -1.7%, a 5.0% gap on every dollar of revenue. On growth, TEAM INC posted the faster year-over-year revenue change (5.4% vs 4.7%). TEAM INC produced more free cash flow last quarter ($14.6M vs $7.6M). Over the past eight quarters, TEAM INC's revenue compounded faster (6.1% CAGR vs 5.6%).

Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.

TeamViewer SE is an international technology company headquartered in Göppingen, Germany. The company became known for the TeamViewer remote access and support software of the same name. Within the TeamViewer software, customers can connect, monitor, and control computers, machines, and other devices. It can be used in various industries, for example, to digitalize processes along the industrial value chain. The company is listed on the stock exchange and is a member of MDAX and TecDAX.

NATR vs TISI — Head-to-Head

Bigger by revenue
TISI
TISI
1.8× larger
TISI
$224.8M
$123.8M
NATR
Growing faster (revenue YoY)
TISI
TISI
+0.7% gap
TISI
5.4%
4.7%
NATR
Higher net margin
NATR
NATR
5.0% more per $
NATR
3.3%
-1.7%
TISI
More free cash flow
TISI
TISI
$7.1M more FCF
TISI
$14.6M
$7.6M
NATR
Faster 2-yr revenue CAGR
TISI
TISI
Annualised
TISI
6.1%
5.6%
NATR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NATR
NATR
TISI
TISI
Revenue
$123.8M
$224.8M
Net Profit
$4.1M
$-3.8M
Gross Margin
72.5%
25.9%
Operating Margin
4.3%
2.9%
Net Margin
3.3%
-1.7%
Revenue YoY
4.7%
5.4%
Net Profit YoY
1379.4%
47.4%
EPS (diluted)
$0.23
$-1.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NATR
NATR
TISI
TISI
Q4 25
$123.8M
$224.8M
Q3 25
$128.3M
$225.0M
Q2 25
$114.8M
$248.0M
Q1 25
$113.2M
$198.7M
Q4 24
$118.2M
$213.3M
Q3 24
$114.6M
$210.8M
Q2 24
$110.6M
$228.6M
Q1 24
$111.0M
$199.6M
Net Profit
NATR
NATR
TISI
TISI
Q4 25
$4.1M
$-3.8M
Q3 25
$5.3M
$-11.4M
Q2 25
$5.3M
$-4.3M
Q1 25
$4.7M
$-29.7M
Q4 24
$-321.0K
$-7.2M
Q3 24
$4.3M
$-11.1M
Q2 24
$1.3M
$-2.8M
Q1 24
$2.3M
$-17.2M
Gross Margin
NATR
NATR
TISI
TISI
Q4 25
72.5%
25.9%
Q3 25
73.3%
25.8%
Q2 25
71.7%
27.5%
Q1 25
72.1%
23.8%
Q4 24
72.0%
26.9%
Q3 24
71.3%
25.4%
Q2 24
71.4%
27.8%
Q1 24
71.2%
24.4%
Operating Margin
NATR
NATR
TISI
TISI
Q4 25
4.3%
2.9%
Q3 25
7.0%
0.6%
Q2 25
3.7%
4.9%
Q1 25
5.4%
-3.0%
Q4 24
3.8%
1.0%
Q3 24
4.6%
1.5%
Q2 24
5.1%
4.9%
Q1 24
4.2%
-3.2%
Net Margin
NATR
NATR
TISI
TISI
Q4 25
3.3%
-1.7%
Q3 25
4.2%
-5.1%
Q2 25
4.6%
-1.7%
Q1 25
4.2%
-15.0%
Q4 24
-0.3%
-3.4%
Q3 24
3.8%
-5.3%
Q2 24
1.2%
-1.2%
Q1 24
2.1%
-8.6%
EPS (diluted)
NATR
NATR
TISI
TISI
Q4 25
$0.23
$-1.46
Q3 25
$0.30
$-2.68
Q2 25
$0.28
$-0.95
Q1 25
$0.25
$-6.61
Q4 24
$-0.02
$-1.60
Q3 24
$0.23
$-2.52
Q2 24
$0.07
$-0.63
Q1 24
$0.12
$-3.89

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NATR
NATR
TISI
TISI
Cash + ST InvestmentsLiquidity on hand
$93.9M
$18.1M
Total DebtLower is stronger
$293.3M
Stockholders' EquityBook value
$161.6M
$-24.5M
Total Assets
$261.1M
$485.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NATR
NATR
TISI
TISI
Q4 25
$93.9M
$18.1M
Q3 25
$95.6M
$14.8M
Q2 25
$81.3M
$20.7M
Q1 25
$86.5M
$16.8M
Q4 24
$84.7M
$35.5M
Q3 24
$78.7M
$19.1M
Q2 24
$68.7M
$22.5M
Q1 24
$77.8M
$24.2M
Total Debt
NATR
NATR
TISI
TISI
Q4 25
$293.3M
Q3 25
$298.8M
Q2 25
$366.4M
Q1 25
$349.8M
Q4 24
$318.6M
Q3 24
$314.2M
Q2 24
$313.0M
Q1 24
$2.1M
$300.0M
Stockholders' Equity
NATR
NATR
TISI
TISI
Q4 25
$161.6M
$-24.5M
Q3 25
$166.7M
$-17.7M
Q2 25
$163.7M
$-22.9M
Q1 25
$167.1M
$-26.0M
Q4 24
$161.0M
$1.7M
Q3 24
$162.6M
$17.9M
Q2 24
$156.4M
$23.9M
Q1 24
$159.7M
$26.3M
Total Assets
NATR
NATR
TISI
TISI
Q4 25
$261.1M
$485.5M
Q3 25
$264.8M
$531.0M
Q2 25
$254.9M
$548.4M
Q1 25
$252.7M
$515.2M
Q4 24
$240.9M
$528.4M
Q3 24
$245.3M
$545.4M
Q2 24
$235.8M
$549.6M
Q1 24
$247.3M
$535.5M
Debt / Equity
NATR
NATR
TISI
TISI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
183.33×
Q3 24
17.55×
Q2 24
13.11×
Q1 24
0.01×
11.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NATR
NATR
TISI
TISI
Operating Cash FlowLast quarter
$9.9M
$16.8M
Free Cash FlowOCF − Capex
$7.6M
$14.6M
FCF MarginFCF / Revenue
6.1%
6.5%
Capex IntensityCapex / Revenue
1.9%
0.9%
Cash ConversionOCF / Net Profit
2.41×
TTM Free Cash FlowTrailing 4 quarters
$28.8M
$-20.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NATR
NATR
TISI
TISI
Q4 25
$9.9M
$16.8M
Q3 25
$18.5M
$3.9M
Q2 25
$4.3M
$-3.3M
Q1 25
$2.6M
$-28.7M
Q4 24
$12.2M
$21.6M
Q3 24
$9.6M
$5.6M
Q2 24
$1.3M
$-6.4M
Q1 24
$2.2M
$1.9M
Free Cash Flow
NATR
NATR
TISI
TISI
Q4 25
$7.6M
$14.6M
Q3 25
$16.8M
$1.0M
Q2 25
$3.0M
$-6.3M
Q1 25
$1.5M
$-30.1M
Q4 24
$10.0M
$19.6M
Q3 24
$7.9M
$3.9M
Q2 24
$-2.0M
$-9.1M
Q1 24
$-1.5M
$-1.1M
FCF Margin
NATR
NATR
TISI
TISI
Q4 25
6.1%
6.5%
Q3 25
13.1%
0.5%
Q2 25
2.6%
-2.5%
Q1 25
1.3%
-15.1%
Q4 24
8.5%
9.2%
Q3 24
6.9%
1.9%
Q2 24
-1.9%
-4.0%
Q1 24
-1.4%
-0.6%
Capex Intensity
NATR
NATR
TISI
TISI
Q4 25
1.9%
0.9%
Q3 25
1.3%
1.3%
Q2 25
1.2%
1.2%
Q1 25
1.0%
0.7%
Q4 24
1.9%
0.9%
Q3 24
1.5%
0.8%
Q2 24
3.0%
1.2%
Q1 24
3.3%
1.5%
Cash Conversion
NATR
NATR
TISI
TISI
Q4 25
2.41×
Q3 25
3.46×
Q2 25
0.81×
Q1 25
0.55×
Q4 24
Q3 24
2.21×
Q2 24
0.97×
Q1 24
0.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NATR
NATR

Other$68.1M55%
General Health Products$20.2M16%
Digestive Products$13.8M11%
Cardiovascular Products$12.1M10%
Personal Care Products$4.4M4%
Immunity Products$3.1M3%
Weight Management Products$2.1M2%

TISI
TISI

Repairand Maintenance Services$114.8M51%
Non Destructive Evaluation And Testing Services$84.9M38%
Heat Treating$14.2M6%
Other Services$9.3M4%

Related Comparisons